Oruka Therapeutics, Inc. (ORKA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -23.58M | -22.59M | -21.6M | -23.14M | -20.87M | -18.82M | -34.86M | -2.63M | -168K | -4.3M | -4.95M | -4.87M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -12.98% | -20.07% | 38.03% | -778.7% | -12322.02% | - | - | - | - | 17.74% | -65.18% | -143.26% |
| Net Income | -31.82M | -29.58M | -30.28M | -24.57M | -21M | -25.78M | -28.62M | -2.68M | -7.08M | -3.27M | -5.68M | -4.71M |
| Depreciation & Amortization | 43K | 28K | 20K | 19K | 16K | 16K | 0 | 12K | 0 | 28K | 28K | 27K |
| Stock-Based Compensation | 0 | 0 | 0 | 5.08M | 4.88M | 0 | 0 | 0 | 85K | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 6.67M | 3.59M | 6.69M | -1.38M | -1.74M | 2.97M | -13.58M | 112K | 1K | 169K | 119K | 104K |
| Working Capital Changes | 1.53M | 3.37M | 1.97M | -2.29M | -3.03M | 3.98M | 7.34M | -80K | 6.82M | -1.22M | 582K | -289K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -493K | 1.95M | 0 | 421K | 83K | 1.84M | 1.41M | 0 | 5.83M | -103K | -6K | -1.07M |
| Cash from Investing | -14.44M | -22.02M | -122.45M | 4.86M | 42.87M | -329.96M | -171K | 0 | 0 | -2K | -7K | -14K |
| Capital Expenditures | -73K | -63K | -99K | -34K | -13K | -18K | -171K | 0 | 0 | -2K | -7K | -14K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -122.35M | 0 | 0 | -329.94M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 40.6M | 298K | 169.91M | 109K | 0 | -526K | 450.05M | 14K | 27.91M | 0 | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 24.98M | 0 | 0 | 0 |
| Equity Issued (Net) | 40.6M | 298K | 0 | 109K | 0 | 29.39M | 420.13M | 14K | 2.93M | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 169.91M | 0 | 0 | -29.92M | 29.92M | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 2.58M | -44.32M | 25.86M | -18.18M | 22M | -349.3M | 377.59M | -2.62M | 27.74M | -4.3M | -4.95M | -4.88M |
| Free Cash Flow | -23.65M | -22.66M | -21.7M | -23.18M | -20.88M | -18.84M | -35.03M | -2.63M | -168K | -4.3M | -4.95M | -4.88M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -13.26% | -20.29% | 38.05% | -779.99% | -12329.76% | - | - | - | - | 17.8% | -64.69% | -143.96% |
| FCF per Share | -0.43 | -0.42 | -0.49 | -0.55 | -0.50 | -1.12 | -2.33 | -0.18 | -0.01 | -3.58 | -4.13 | -4.07 |
| FCF Conversion (FCF/Net Income) | 0.74x | 0.76x | 0.71x | 0.94x | 0.99x | 0.56x | 1.22x | 0.12x | 0.08x | 1.31x | 0.87x | 1.03x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |